2025 Annual Meeting | PL7 - Neurology Year in Review Plenary Session

Date Tuesday 04/08/25

Time 01:45 PM - 04:15 PM PDT Add To Calendar

Location San Diego Convention Center | Ballroom 20

Session Format This program will be presented online only

On Demand This program will be available in the meeting's On Demand product.

Event Type Plenary Session

Director(s) Erika F. Augustine, MD, FAAN

Topic(s) General Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Epilepsy/Clinical Neurophysiology (EEG), Movement Disorders, Neuromuscular and Clinical Neurophysiology (EMG), Sleep

Learning Objectives This session will feature six speakers, each focusing on the latest developments of interest to the clinician that have occurred in a specific subspecialty topic.

CME Available 3.00 CME credits

Program Materials Program Evaluations

Event Timeline
01:45 PM - 02:10 PM PDT	Speaker	Breakthrough Therapies for Pediatric Neurological Disorders Jennifer A. Vermilion, MD
02:10 PM - 02:35 PM PDT	Speaker	Surgical Treatments for Epilepsy Sasha Alick-Lindstrom, MD, MPH, FACNS, FAES, FAAN
02:35 PM - 03:00 PM PDT	Speaker	Updates in the Management of Advanced Parkinson’s Disease Okeanis Vaou, MD, FAAN
03:00 PM - 03:25 PM PDT	Speaker	Updates in Myasthenia Gravis Karissa Gable, MD
03:25 PM - 03:50 PM PDT	Speaker	Thrombectomy for Large Core Ischemic Strokes Ronda Lun, MD
03:50 PM - 04:15 PM PDT	Speaker	New Perspectives on Restless Legs Syndrome Management John Winkelman, MD, PhD

Faculty Disclosures
Erika F. Augustine, MD, FAAN	The institution of Dr. Augustine has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Latus Bio. Dr. Augustine has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. Dr. Augustine has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for American Board of Psychiatry and Neurology. Dr. Augustine has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink. Dr. Augustine has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. The institution of Dr. Augustine has received research support from NIH. The institution of Dr. Augustine has received research support from Beyond Batten Disease Foundation. Dr. Augustine has received publishing royalties from a publication relating to health care. Dr. Augustine has a non-compensated relationship as a Member, Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
Jennifer A. Vermilion, MD	The institution of Dr. Vermilion has received research support from Centers for Disease Control. The institution of Dr. Vermilion has received research support from Emalex Biosciences. The institution of Dr. Vermilion has received research support from Biomarin. The institution of Dr. Vermilion has received research support from Neurogene, Inc. Dr. Vermilion has received personal compensation in the range of $500-$4,999 for serving as a Invited Speaker with Tourette Association of America. Dr. Vermilion has received personal compensation in the range of $500-$4,999 for serving as a Invited Speaker with Centers for Disease Control and Prevention and American Academy of Pediatrics.
Okeanis Vaou, MD, FAAN	Dr. Vaou has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ABBVIE. Dr. Vaou has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Vaou has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic . Dr. Vaou has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for medtronic. An immediate family member of Dr. Vaou has stock in SAGE. The institution of Dr. Vaou has received research support from Medtronic.
Karissa Gable, MD	Dr. Gable has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Accordant. Dr. Gable has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant. Dr. Gable has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Gable has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Gable has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Gable has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astrazenca. Dr. Gable has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Gable has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. Gable has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols . Dr. Gable has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for annexon. Dr. Gable has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Gable has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Gable has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx.
Sasha Alick-Lindstrom, MD, MPH, FACNS, FAES, FAAN	Dr. Alick-Lindstrom has received personal compensation in the range of $5,000-$9,999 for serving as a consultant with megin.
John Winkelman, MD, PhD	John Winkelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexza. John Winkelman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Azurity. John Winkelman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Disc Medicine. An immediate family member of John Winkelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Emalex. John Winkelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentec. John Winkelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Haleon. John Winkelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. John Winkelman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Noctrix. John Winkelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Psychogenics. The institution of John Winkelman has received research support from American Regent. The institution of John Winkelman has received research support from Merck. John Winkelman has received publishing royalties from a publication relating to health care. John Winkelman has a non-compensated relationship as a Chair with International Restless Legs Syndrome Study Group that is relevant to AAN interests or activities. John Winkelman has a non-compensated relationship as a Member with Restless Legs Syndrome Foundation Scientific Medical Advisory Board that is relevant to AAN interests or activities.
Ronda Lun, MD	Dr. Lun has nothing to disclose.

��ɫ��

��ɫ��